Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 3 Innovations Improving Neuropsychological Testing in CNS Drug Development By Krista Armstrong January 16, 2017 Clinical ResearchPhase 1 - Phase 4 The Why, What, and How of the Current State of CNS Drug Development By Krista Armstrong January 13, 2017 Clinical ResearchPhase 1 - Phase 4 The 7 Most Important Steps for Success in Neurodegenerative Disease Trial Design By Krista Armstrong December 9, 2016 Consulting ‘Trailblazers’ needed to combat the agonizing scourge of addiction By Krista Armstrong October 20, 2016 Previous 1 2 3 × ALSO OF INTERESTForging Strong Sponsor-CRO Relationships: Join...Premier Research Strategist to Discuss...Developing Best Practices for Forging...
